World Gym Explores U.S. Listing, Launches Biomarker-Driven Longevity Program

Event summary

  • World Gym presented at the 2026 ICR Conference, exploring a potential U.S. capital markets listing.
  • The company highlighted 70%+ member retention rates and 50% of revenues from personal training.
  • World Gym announced a new longevity program integrating blood and DNA assessments for personalized fitness plans.
  • 2025 EBITDA was $60M, with expectations of $80M+ in 2026.
  • The company operates 280 locations across 10 countries with 900,000 members.

The big picture

World Gym's exploration of a U.S. listing comes as the fitness industry increasingly converges with health tech, particularly around personalized wellness. The company's strong retention rates and high-margin personal training business position it well for expansion, but scaling its new digital health offerings will be key to sustaining growth. With 900,000 members across 280 locations, World Gym is betting on biomarker integration to differentiate itself in a competitive market.

What we're watching

Listing Strategy
Whether World Gym can successfully navigate a U.S. listing after its Taiwan debut.
Program Adoption
The pace at which members adopt the biomarker-driven longevity program and its impact on recurring revenue.
Asia Expansion
How World Gym will replicate its Taiwan success in new markets like Thailand.